Involvement of DNA methylation in the control of the expression of an estrogen-induced breast-cancer-associated protein (pS2) in human breast cancers

Journal of Cellular Biochemistry

Volumn 65, Issue 1, 1997, Pages 95-106

  Martin, Valérie ^a   Ribieras, Stéphane ^a   Song Wang, Xiu Gin ^a   Lasne, Yves ^b   Frappart, Lucien ^b   Rio, Marie Christine ^c   Dante, Robert ^a  

^a CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c CNRS   (France)

Author keywords

5 methyldeoxycytidine; breast cancers; genomic sequencing; multiple component analysis; pS2; RT PCR

Indexed keywords

DNA; ESTROGEN; ESTROGEN RECEPTOR; MESSENGER RNA; ONCOPROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DNA METHYLATION; ENHANCER REGION; GENE EXPRESSION REGULATION; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; TRANSCRIPTION REGULATION;

DNA METHYLATION; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; PROTEINS; RECEPTORS, ESTROGEN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0030906551     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(199704)65:1<95::AID-JCB10>3.0.CO;2-G     Document Type: Article

References (40)

1. Adams RLP (1990): DNA methylation: The effect of minor bases on DNA-protein interactions. Biochem J 265:309-320.
2. Berry M, Nunez JM, Chambon P (1989): Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc Natl Acad Sci U S A 86:1218-1222.
3. Bird A (1992): The essentials of DNA methylation. Cell 70:5-8.
4. Counts JL, Goodman JI (1995): Alteration in DNA methylation may play a variety of roles in carcinogenesis. Cell 83:13-15.
5. Dante R, Ribieras S, Baldassini S, Martin V, Benzerara O, Bouteille C, Brémond A, Frappart L, Rio MC, Lasne Y (1994): Expression of an estrogen-induced breast cancer associated protein (pS2) in benign and malignant human ovarian cysts. Lab Invest 71:188-192.
6. Doerfler W (1983): DNA methylation and gene activity. Annu Rev Biochem 52:93-124.
7. Feil R, Wakter J, Allen ND, Reik W (1994): Developmental control of allelic methylation in the imprinted mouse Igf2 and H19 genes. Development 120:2933-2943.
8. Feinberg AP, Vogelstein B (1983): Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301:89-92.
9. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL (1992): A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 89:1827-1831.
10. Fuqua SAW, Falette NF, McGuire WL (1990): Sensitive detection of estrogen receptor RNA by polymerase chain reaction assay. J Natl Cancer Inst 82:858-861.
11. Fuqua SAW, Fitzgerald SD, Allred DC, Elledge MR, Nawaz Z, McDonell DP, O'Malley BW, Greene GL, McGuire WL (1992): Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res 52:483-486.
12. Gama-Sosa M, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, Gehrke CW, Ehrlich M (1983): The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 11:6883-6894.
13. Henry JA, Piggott NH, Mallick UK, Nicholson S, Farndon JR, Westley BR, May FEB (1991): pNR-2/pS2 immunohistochemical staining in breast cancer: Correlation with prognostic factors and endocrine response. Br J Cancer 63:615-622.
14. Jeltsch JM, Roberts M, Schatz C, Gamier JM, Brown A, Chambon P (1987): Structure of the human estrogen-responsive gene pS2. Nucleic Acids Res 15:1404-1414.
15. Jost JP (1993): Nuclear extracts of chicken embryos promote an active demethylation of DNA by excision repair of 5-methyldeoxycytidine. Proc Natl Acad Sci U S A 90:4684-4688.
16. Kafri T, Gao X, Razin A (1993): Mechanistic aspects of genome-wide demethylation in the preimplantation mouse embryo. Proc Natl Acad Sci U S A 90:10558-10562.
17. Kumar V, Chambon P (1988): The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55:145-156.
18. Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P (1987): Functional domains of the human estrogen receptor. Cell 51:941-951.
19. Laird PW, Jaenisch R (1994): DNA methylation and cancer. Hum Mol Genet 3:1487-1495.
20. Lebart L, Morineau A, Warwick KM (1984): "Multivariate Descriptive Statistical Analysis. Correspondence Analysis and Related Techniques for Large Matrices." New York: John Wiley & Sons, Inc.
21. Lefebvre O, Chenard MP, Masson R, Linares J, Dierich A, LeMeur M, Wendling C, Tomasetto C, Chambon P, Rio MC (1996): Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274: 259-262.
22. Li E, Bestor TH, Jaenisch R (1992): Targeted mutation of DNA methyltransferase gene results in embroyonic lethality. Cell 6:915-926.
23. Martin V, Ribieras S, Song-Wang X, Rio MC, Dante R (1995): Genomic sequencing indicates a correlation between DNA hypomethylation in the 5′ region of the pS2 and its expression in human breast cell lines. Gene 157:261-264.
24. Masiakowski P, Breathnach R, Bloch J, Gannon K, Krust A, Chambon P (1982): Cloning of cDNA sequences of hormone-regulated genes from MCF-7 human breast cancer cell lines. Nucleic Acids Res 19:7895-7903.
25. Nunez JM, Berry M, Imler JL, Chambon P (1989): The 5′ flanking region of the pS2 contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumor promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. EMBO J 8:823-829.
26. Park JG, Chapman VM (1994): CpG island promoter region methylation patterns of the inactive-X-chromosome hypoxanthine phosphoribosyltransferase (Hprt) gene. Mol Cell Biol 14:7975-7983.
27. Playford RJ, Marchbank T, Goodlad RA, Chinery RA, Poulsom R, Hanby AM, Wright NA (1996): Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad Sci U S A 93:2137-2142.
28. Razin A, Cedar H (1991): DNA methylation and gene expression. Microbiol Rev 55:451-458.
29. Ribieras S, Song-Wang X-W, Martin V, Lointier P, Frappart L, Dante R (1994): Human breast and colon cancers exhibit alterations of DNA methylation patterns at several DNA segments on chromosomes 11p and 17p. J Cell Biochem 56:86-96.
30. Rio MC, Bellocq JP, Gairard B, Rasmussen UB, Krust A, Koehl C, Calderoli H, Schiff V, Renaud R, Chambon P (1987): Specific expression of the pS2 in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc Natl Acad Sci U S A 84:9243-9247.
31. Rio MC, Bellocq JP, Daniel JY, Thomasetto C, Lathe R, Chenard MP, Batzenschlager A, Chambon P (1988): Breast cancer-associated pS2 protein: Synthesis and secretion by normal stomach mucosa. Science 241:705-707.
32. Saluz HP, Jiricny J, Jost JP (1986): Genomic sequencing reveals a positive correlation between the kinetics of strand-specific DNA demethylation of the overlapping estradiol/glucocorticoid-receptor binding site and the rate of avian vitellogenin mRNA synthesis. Proc Natl Acad Sci U S A 83:7167-7171.
33. Sambrook J, Fritsch EF, Maniatis T (1989): "Molecular Cloning: A Laboratory Manual," 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
34. Schwartz LH, Koerner FC, Edgerton SM, Sawicka JM, Rio MC, Bellocq JP, Chambon P, Thor AD (1991): pS2 expression and response to hormonal therapy in patients with advanced breast cancer. Cancer Res 51:624-628.
35. Scott GK, Kushner P, Vigne JL, Benz CC (1991): Truncated forms of DNA-binding estrogen receptors in human breast cancer. J Clin Invest 88:700-706.
36. Thioulouse J, Dolédec S, Chessel D, Olivier JM (1994): ADE software: Multivariate analysis and graphical display of environmental data. In Guariso G, Rizzoli A (eds): "Software per l'ambiente." Bologna: Pàtron editore, pp 57-62.
37. Tora L, Mullick A, Metzger D, Ponglitikmongkol M, Park I, Chambon P (1989): The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J 8:1981-1986.
38. Welter C, Theisinger B, Seitz G, Tomasetto C, Rio MC, Chambon P, Blin N (1992): Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma. Lab Invest 66:187-192.
39. Wysoki SJ, Hahnel E, Masters A, Smith V, McCartney AJ, Hahnel R (1990): Detection of pS2 messenger RNA in gynecological cancers. Cancer Res 50:1800-1802.
40. Zajchowski DA, Sager R (1991): Induction of estrogen-regulated genes differs in immortal and tumorigenic human mammary epithelial cells expressing a recombinant estrogen receptor. Mol Endocrinol 5:1613-1623.